(Reuters) – Walgreens Boots Alliance (NASDAQ:) agreed to pay $106.8 million to settle fees it billed the U.S. authorities for prescriptions that have been by no means disbursed, the Division of Justice stated on Friday.
The Justice Division stated that from 2009 to 2020, Walgreens submitted false claims for cost to Medicare, Medicaid and different federal well being care packages for prescriptions it processed however which have been by no means picked up.
Greg Abel, CEO of Berkshire Hathaway, speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska, May 2, 2026.CNBCBerkshire...
The S&P 500 dividend yield just hit an all-time low of 1.08%, the lowest since the 1800s. The prior low...
By Kamal Choudhury and Christy Santhosh April 29 (Reuters) - on Wednesday reported better-than-expected quarterly revenue and profit, fueled by...
10 years doesn’t sound like much. It’s the gap between graduating high school and turning 28. It’s the decade most...
The good news? Looks like the market has decided that the war is over, and everything will get back to...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
